Johnny Ludvigsson Selected Research

aluminum sulfate (alum)

5/2022	Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial).
1/2022	Association between treatment effect on C-peptide preservation and HbA1c in meta-analysis of glutamic acid decarboxylase (GAD)-alum immunotherapy in recent-onset type 1 diabetes.
1/2022	Glutamic acid decarboxylase immunotherapy for type 1 diabetes.
1/2022	Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2.
1/2022	Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes.
10/2021	Combined Etanercept, GAD-alum and vitamin D treatment: an open pilot trial to preserve beta cell function in recent onset type 1 diabetes.
1/2021	Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial.
1/2021	Intralymphatic GAD-alum Injection Modulates B Cell Response and Induces Follicular Helper T Cells and PD-1+ CD8+ T Cells in Patients With Recent-Onset Type 1 Diabetes.
10/2020	Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes.
1/2020	Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johnny Ludvigsson Research Topics

Disease

119	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2022 - 01/2002
15	Infections 09/2021 - 01/2002
7	Type 2 Diabetes Mellitus (MODY) 11/2021 - 03/2006
7	Obesity 03/2020 - 10/2006
6	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2006
5	Celiac Disease (Celiac Sprue) 01/2021 - 03/2010
5	Hypoglycemia (Reactive Hypoglycemia) 03/2020 - 05/2006
5	Ketosis 02/2018 - 01/2002
5	Insulin Resistance 01/2017 - 02/2005
3	Inflammation (Inflammations) 01/2021 - 10/2006
3	Disease Susceptibility (Diathesis) 01/2021 - 01/2015
3	Insulinoma 01/2021 - 01/2017
3	Gastroenteritis 01/2017 - 01/2002
2	Necrosis 10/2021 - 10/2010
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2021 - 07/2019
2	Birth Weight (Birth Weights) 01/2021 - 11/2013
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2020 - 08/2006
2	Disease Progression 01/2020 - 01/2017
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019 - 05/2009
2	Glucose Intolerance 01/2019 - 01/2017
2	Diabetes Mellitus 08/2014 - 08/2014
2	Pain (Aches) 05/2009 - 03/2002
2	Diabetes Complications 05/2009 - 01/2006
1	Albuminuria 06/2022
1	COVID-19 05/2021
1	Hypersensitivity (Allergy) 03/2020
1	Lipoma (Lipomata) 03/2020
1	Neoplasms (Cancer) 03/2020
1	Phobic Disorders (Phobia) 03/2020
1	Hyperglycemia 01/2020
1	Overweight 01/2020
1	Hypertension (High Blood Pressure) 01/2020

Drug/Important Bio-Agent (IBA)

37	Insulin (Novolin)FDA Link 11/2021 - 03/2002
31	AutoantibodiesIBA 01/2021 - 04/2002
23	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2022 - 03/2006
23	C-PeptideIBA 01/2022 - 11/2006
22	aluminum sulfate (alum)IBA 05/2022 - 10/2008
12	AntigensIBA 07/2021 - 06/2008
9	AutoantigensIBA 01/2022 - 11/2006
9	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 01/2002
9	AntibodiesIBA 01/2021 - 04/2002
7	Zinc Transporter 8IBA 01/2021 - 08/2011
7	Glutens (Glutelin)IBA 08/2014 - 03/2006
6	CytokinesIBA 01/2014 - 02/2005
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2013
5	Vitamin D FDA LinkGeneric 10/2021 - 02/2007
5	HLA-DQ Antigens (HLA-DQ)IBA 01/2021 - 10/2012
5	AluminumIBA 01/2021 - 01/2011
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 08/2007
4	Anti-Bacterial Agents (Antibiotics)IBA 09/2021 - 04/2014
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021 - 02/2005
4	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 02/2005
4	Amino Acids FDA Link 11/2020 - 03/2016
4	VaccinesIBA 08/2017 - 05/2009
3	LipidsIBA 06/2022 - 05/2009
3	teplizumabIBA 11/2019 - 08/2011
3	hydroxide ionIBA 03/2017 - 01/2011
3	Immunoglobulin G (IgG)IBA 01/2017 - 10/2010
3	Proteins (Proteins, Gene)FDA Link 10/2006 - 04/2006
2	CholesterolIBA 06/2022 - 01/2020
2	Biological ProductsIBA 01/2022 - 01/2017
2	HLA-DRB1 Chains (HLA DRB1)IBA 07/2021 - 01/2019
2	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2021 - 01/2018
2	HLA-DQA1 antigen (HLA DQA1)IBA 11/2020 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 03/2020 - 01/2002
2	HLA-DRB3 Chains (HLA DRB3)IBA 01/2019 - 03/2016
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 01/2014
2	MicronutrientsIBA 11/2016 - 03/2012
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2014 - 02/2012
2	Protein Isoforms (Isoforms)IBA 02/2012 - 10/2008
2	InterleukinsIBA 10/2010 - 04/2006
1	oxidized low density lipoproteinIBA 06/2022
1	Triglycerides (Triacylglycerol)IBA 06/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Etanercept (Enbrel)FDA Link 10/2021
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 07/2021
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Pharmaceutical PreparationsIBA 03/2020
1	InsulinsIBA 03/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2020
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	GlucokinaseIBA 01/2020
1	P-2 (P 2)IBA 01/2020
1	HDL LipoproteinsIBA 01/2020
1	Heavy MetalsIBA 07/2019
1	casein hydrolysateIBA 01/2018
1	Dietary ProteinsIBA 01/2018
1	Caseins (Casein)FDA Link 01/2018

Therapy/Procedure

12	Therapeutics 10/2021 - 03/2005
5	Glycemic Control 01/2022 - 05/2009
3	Immunotherapy 01/2022 - 10/2020
3	Immunomodulation 01/2022 - 03/2009
3	Injections 05/2012 - 03/2002
2	Intralymphatic Injections 01/2017 - 01/2017
2	Gluten-Free Diet 02/2014 - 05/2011
1	Precision Medicine 01/2022
1	Critical Care (Surgical Intensive Care) 05/2021